13F filer · CIK 1510481 ↗
Sarasin & Partners LLP
You are looking at Q2 2025. See the latest, Q3 2026 →
Reported value
$10.05B
+8.9% on the quarter before
Positions
80
6 new · 7 sold out
Top 10
48.8%
of the value
Est. gain
+$832.5M
on stocks held all quarter
Est. return
+9.7%
on those stocks since Q1 2025
Positions as of Jun 30, 2025, from Sarasin & Partners LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2025. Striped tiles are options.
Largest buys
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Marsh & Mclennan Cos Inc~$122.3MNew · 0.0% → 1.2%+559,328 shares
- Netflix~$107.9MAdded · 0.2% → 1.3%+80,607 shares
- ServiceNow~$77.9MAdded · 0.6% → 1.5%+75,789 shares
- Broadcom~$53.9MAdded · 1.1% → 2.2%+195,466 shares
- MercadoLibre~$39.7MAdded · 1.3% → 2.0%+15,201 shares
- Fortinet~$33.3MAdded · 2.6% → 3.0%+314,593 shares
- Emerson Electric~$25.5MAdded · 2.6% → 3.2%+191,255 shares
- Colgate Palmolive Co~$20.7MAdded · 3.9% → 3.7%+228,166 shares
- Unitedhealth Group Inc~$15.8MAdded · 3.1% → 1.9%+50,657 shares
- Amgen Inc~$15.2MAdded · 1.9% → 1.7%+54,580 shares
Largest sells
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- TSMC~$243.9MSold out · 2.6% → 0.0%−1,469,127 shares
- Apple~$79.4MCut · 4.3% → 2.9%−386,965 shares
- Thermo Fisher Scientific Inc~$48.4MCut · 2.0% → 1.0%−119,485 shares
- Cme Group Inc~$43.5MCut · 3.4% → 2.8%−157,718 shares
- Mastercard~$29.5MCut · 4.5% → 4.0%−52,492 shares
- Deere & Co~$27.2MCut · 2.3% → 2.0%−53,575 shares
- Blackrock Inc~$21.9MCut · 2.5% → 2.3%−20,893 shares
- Kimberly-Clark Corp~$16.8MCut · 1.9% → 1.4%−129,934 shares
- Moody's Corporation~$12.9MCut · 2.3% → 2.1%−25,731 shares
- Microsoft~$11.1MCut · 8.6% → 10.4%−22,285 shares
Holdings
As of Jun 30, 2025. Changes are in shares against Mar 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −1.1% · price +32.5% | 10.4% | $1.04B | +$256.2M | ||||||||
| NvidiaCOM · shares +1.9% · price +45.8% | 6.2% | $620.1M | +$191.1M | ||||||||
| AmazonCOM · shares +1.0% · price +15.3% | 5.5% | $556.5M | +$73.2M | ||||||||
| MetaCL A · shares −1.7% · price +28.1% | 4.6% | $466.6M | +$102.2M | ||||||||
| AlphabetCAP STK CL A · shares −2.4% · price +14.0% | 4.4% | $440.6M | +$54.0M | ||||||||
| MastercardCL A · shares −6.9% · price +2.5% | 4.0% | $397.5M | +$9.8M | ||||||||
| Colgate Palmolive CoCOM · shares +5.9% · price −3.0% | 3.7% | $372.9M | −$10.8M | ||||||||
| Otis Worldwide CorpCOM · shares −1.7% · price −4.1% | 3.5% | $354.6M | −$15.0M | ||||||||
| Jpmorgan Chase & Co.COM · shares +4.7% · price +18.2% | 3.2% | $326.2M | +$47.9M | ||||||||
| Emerson ElectricCOM · shares +8.6% · price +21.6% | 3.2% | $322.4M | +$52.8M | ||||||||
| FortinetCOM · shares +13% · price +9.8% | 3.0% | $296.9M | +$23.6M | ||||||||
| AppleCOM · shares −22% · price −7.6% | 2.9% | $286.6M | −$23.7M | ||||||||
| Cme Group IncCOM · shares −13% · price +3.9% | 2.8% | $279.7M | +$10.5M | ||||||||
| Zoetis IncCL A · shares +3.7% · price −5.3% | 2.5% | $251.3M | −$13.5M | ||||||||
| Home Depot IncCOM · shares +1.0% · price +0.0% | 2.4% | $245.9M | +$99,627 | ||||||||
| Costco Whsl Corp NewCOM · shares −0.08% · price +4.7% | 2.3% | $235.4M | +$10.5M | ||||||||
| Blackrock IncCOM · shares −8.6% · price +10.9% | 2.3% | $234.2M | +$22.9M | ||||||||
| BroadcomCOM · shares +32% · price +64.6% | 2.2% | $223.5M | +$66.6M | ||||||||
| Moody's CorporationCOM · shares −5.8% · price +7.7% | 2.1% | $210.8M | +$15.1M | ||||||||
| Deere & CoCOM · shares −12% · price +8.3% | 2.0% | $204.3M | +$15.7M | ||||||||
| MercadoLibreCOM · shares +25% · price +34.0% | 2.0% | $199.4M | +$40.5M | ||||||||
| Unitedhealth Group IncCOM · shares +9.1% · price −40.4% | 1.9% | $188.7M | −$117.4M | ||||||||
| Eli LillyCOM · shares +4.3% · price −5.6% | 1.8% | $185.4M | −$10.6M | ||||||||
| American TowerCOM · shares −3.5% · price +1.6% | 1.7% | $171.6M | +$2.7M | ||||||||
| Amgen IncCOM · shares +9.8% · price −10.4% | 1.7% | $170.9M | −$18.0M | ||||||||
| Total · 80 positions | 100% | $10.05B | +$832.5M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2025 to Q2 2025: 74 stocks held throughout, up $832.5M (+9.7%).
- Microsoft+$256.2M+33%
- Nvidia+$191.1M+46%
- Meta+$102.2M+28%
- Amazon+$73.2M+15%
- Broadcom+$66.6M+65%
- Otis Worldwide Corp−$15.0M−4%
- Amgen Inc−$18.0M−10%
- Thermo Fisher Scientific Inc−$23.6M−19%
- Apple−$23.7M−8%
- Unitedhealth Group Inc−$117.4M−40%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 13, 2026 | $8.93B+5% | SEC ↗ |
| Q2 2026 | Jul 7, 2026 | $8.54B+4% | SEC ↗ |
| Q1 2026 | Apr 13, 2026 | $8.20B−15% | SEC ↗ |
| Q4 2025 | Jan 8, 2026 | $9.63B−5% | SEC ↗ |
| Q3 2025 | Oct 10, 2025 | $10.19B+1% | SEC ↗ |
| Q2 2025 | Jul 9, 2025 | $10.05B+9% | SEC ↗ |
| Q1 2025 | Apr 15, 2025 (amended) | $9.22B+2% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $9.06B−14% | SEC ↗ |
| Q3 2024 | Oct 9, 2024 | $10.60B−6% | SEC ↗ |
| Q2 2024 | Jul 19, 2024 | $11.29B+11% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $10.16B+12% | SEC ↗ |
| Q4 2023 | Jan 10, 2024 | $9.10B+14% | SEC ↗ |
| Q3 2023 | Oct 5, 2023 | $8.01B−7% | SEC ↗ |
| Q2 2023 | Jul 11, 2023 | $8.62B−54% | SEC ↗ |
| Q1 2023 | Apr 27, 2023 (amended) | $18.57B+143% | SEC ↗ |
| Q4 2022 | Jan 30, 2023 | $7.64B+6% | SEC ↗ |
| Q3 2022 | Oct 18, 2022 | $7.22B−9% | SEC ↗ |
| Q2 2022 | Jul 13, 2022 | $7.93B−20% | SEC ↗ |
| Q1 2022 | Apr 11, 2022 | $9.95B−9% | SEC ↗ |
| Q4 2021 | Jan 19, 2022 | $10.98B+11% | SEC ↗ |
| Q3 2021 | Oct 22, 2021 | $9.91B+3% | SEC ↗ |
| Q2 2021 | Jul 13, 2021 | $9.58B+13% | SEC ↗ |
| Q1 2021 | Apr 29, 2021 | $8.48B+12% | SEC ↗ |
| Q4 2020 | Jan 19, 2021 | $7.56B+9% | SEC ↗ |
| Q3 2020 | Nov 9, 2020 | $6.91B+11% | SEC ↗ |
| Q2 2020 | Jul 17, 2020 | $6.25B+23% | SEC ↗ |
| Q1 2020 | Apr 30, 2020 | $5.09B−22% | SEC ↗ |
| Q4 2019 | Feb 12, 2020 | $6.54B+8% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $6.04B+6% | SEC ↗ |
| Q2 2019 | Jul 18, 2019 | $5.72B+10% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $5.19B+13% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $4.60B−13% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $5.31B+4% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $5.09B−0% | SEC ↗ |
| Q1 2018 | May 1, 2018 | $5.11B−1% | SEC ↗ |
| Q4 2017 | Feb 6, 2018 | $5.15B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $4.96B−3% | SEC ↗ |
| Q2 2017 | Aug 3, 2017 | $5.11B−1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $5.14B−13% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $5.91B−7% | SEC ↗ |
| Q3 2016 | Oct 14, 2016 | $6.38B+6% | SEC ↗ |
| Q2 2016 | Jul 14, 2016 | $6.02B−2% | SEC ↗ |
| Q1 2016 | Apr 27, 2016 | $6.13B | SEC ↗ |